Zorvolex Approval History
- FDA approved: Yes (First approved October 18th, 2013)
- Brand name: Zorvolex
- Generic name: diclofenac
- Company: Iroko Pharmaceuticals, LLC
- Treatment for: Pain, Osteoarthritis
Zorvolex (diclofenac) is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of mild to moderate acute pain, and for the management of osteoarthritis pain.
Development History and FDA Approval Process for Zorvolex
|Aug 25, 2014||Iroko Pharmaceuticals Gains FDA Approval of Zorvolex for Management of Osteoarthritis Pain|
|Oct 18, 2013||Iroko Pharmaceuticals Receives FDA Approval for Zorvolex|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.